IL-6 and IL-1 β are involved in IR, which is mediated through the underexpression of insulin receptor substrate-1 (IRS-1), and also suppress the activity of lipoprotein lipase, resulting in hypertriglyceridemia [40]. Here, IL6 is linked to hypertriglyceridemia.